Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Meiwei Gong"'
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 1, Pp 18-27 (2023)
Objective: In minimal residual disease (MRD) analysis after allogeneic hematopoietic stem cell transplantation (allo-HSCT), abnormal immunophenotyping is commonly considered as evidence of a secondary recurrence or complications, leading to overtreat
Externí odkaz:
https://doaj.org/article/7d09725dfc71435d9a0edcad2eaf0523
Autor:
Man Chen, Minjing Fu, Wei Zhao, Aixian Wang, Xueying Wu, Meiwei Gong, Junyi Zhen, Guanlan Yue, Hui Wang
Publikováno v:
International Journal of Laboratory Hematology. 45
Publikováno v:
Open Medicine; Jan2023, Vol. 18 Issue 1, p1-11, 11p, 3 Color Photographs, 3 Graphs
Autor:
Junyi Zhen, Haiyan Gao, Xueying Wu, Tong Wang, Ting Li, Lina Zhang, Hui Wang, Minjing Fu, Qing Du, Meiwei Gong, Xiaoge Zhou, Aixian Wang, Man Chen, Huipeng Sun, Hongxing Liu, Ping Wu
Background: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is the most prevalent adult leukemia, and its incidence continues to rise year after year. Rapid and precise diagnosis is an essential element in effective case management,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19c408d5d544990a493688baa3eb797b
https://doi.org/10.21203/rs.3.rs-621348/v1
https://doi.org/10.21203/rs.3.rs-621348/v1
Autor:
Hui, Wang, Hongqin, Liu, Aixian, Wang, Junyi, Zhen, Xueying, Wu, Man, Chen, Meiwei, Gong, Hao, Qu, Shan, Zhou, Xinyong, Tao, Xiaolong, Liao
Publikováno v:
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 36(2)
Objective To prepare a monoclonal antibody (mAb) against human CD33 by immunizing mice with recombinant vector and analyze its characteristics and clinical application. Methods The eukaryotic expression vector pcDNA3.1(+)/CD33 was constructed and use
Autor:
Minjing Fu, Aixian Wang, Meiwei Gong, Hui Wang, Man Chen, Xueying Wu, Junyi Zhen, Shuqiang Liu
Publikováno v:
Indian J Hematol Blood Transfus
T cell therapy represents a new class of immunotherapies garnering considerable attention. T cell receptor beta chain constant region 1 (TRBC1) is partially expressed in subsets of normal T cells. However, the immunotherapy of T lymphocyte tumors is
Publikováno v:
Blood. 136:39-40
Introduction Multicolor flow cytometry (MFC) has been frequently adopted as a method for minimal residual disease (MRD) detection, and is also a promising technique to detect post-transplant lymphoproliferative disorder. Some abnormal donor origin ce
Autor:
Xueying Wu, Hui Wang, Peihua Lu, Aixian Wang, Meiwei Gong, Xing-Yu Cao, Man Chen, Qing Du, Junyi Zhen
Publikováno v:
Blood. 136:47-47
Background Post-transplant lymphoproliferative disorder (PTLD) is a serious complication that can occur following an allogenic hematopoietic stem cell transplant (allo-HSCT). PTLD occurs in approximately 0.8% to 20% of patients following an allo-HSCT
Publikováno v:
ACS Catalysis. 5:45-50
Although transition-metal-catalyzed direct arylation of aromatic C–H bonds is one of the most efficient ways for the construction of biaryl targets, it is also expected for other alternative methods that can use inexpensive catalysts and abundant s